We are live on ! Find out more
IIP

Intermede Investment Partners Portfolio holdings

AUM $2.16B
1-Year Est. Return 18.47%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+18.47%
3 Year Est. Return
+69.55%
5 Year Est. Return
+72.34%
10 Year Est. Return
+364.13%
AUM
$1.26B
AUM Growth
+$99.5M
Cap. Flow
+$55.5M
Cap. Flow %
4.39%
Top 10 Hldgs %
50.76%
Holding
28
New
3
Increased
10
Reduced
14
Closed
1

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$44.5M
2
TV icon
Televisa
TV
+$31.7M
3
ZTS icon
Zoetis
ZTS
+$13.8M
4
SPGI icon
S&P Global
SPGI
+$11.9M
5
ORCL icon
Oracle
ORCL
+$9.85M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$52M
2
TJX icon
TJX Companies
TJX
+$8.92M
3
HDB icon
HDFC Bank
HDB
+$4.55M
4
BABA icon
Alibaba
BABA
+$2.56M
5
CME icon
CME Group
CME
+$2.15M

Sector Composition

Rank Sector Weight
1 Financials 24.49%
2 Communication Services 19.22%
3 Healthcare 17.95%
4 Technology 16.84%
5 Consumer Discretionary 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HDB icon
26
HDFC Bank
HDB
$123B
$2.06M 0.16%
78,396
-182,192
-70% -$4.55M
IVR icon
27
Invesco Mortgage Capital
IVR
$759M
$382K 0.03%
+2,400
New +$389K
MDT icon
28
Medtronic
MDT
$109B
– –
-648,808
Closed -$52M
1
2

Similar funds

MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
MMLI
Massachusetts Mutual Life Insurance Springfield, Massachusetts $2.17B AUM 48.68% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return

Intermede Investment Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Intermede Investment Partners held 28 positions worth $1.26B, up 8.5% from $1.16B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Intermede Investment Partners deployed $55.5M of net new capital in Q2 2018, opening 3 new positions and adding to 10 existing holdings. Its largest new stake was Colgate-Palmolive: 680,959 shares worth $44.1M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was TJX Companies, an estimated $8.92M trimmed.

  • Intermede Investment Partners's largest Q2 2018 buy was Colgate-Palmolive: 680,959 shares worth $44.1M.
  • Intermede Investment Partners added most to Zoetis in Q2 2018, an estimated $13.8M increase.
  • Intermede Investment Partners's biggest Q2 2018 reduction was TJX Companies, cutting an estimated $8.92M.
  • Intermede Investment Partners fully exited Medtronic in Q2 2018, selling an estimated $52M.
  • Intermede Investment Partners's ten largest holdings make up 51% of its $1.26B portfolio in Q2 2018.
  • Intermede Investment Partners opened 3 new positions and closed 1 in Q2 2018.
  • Intermede Investment Partners's portfolio value rose 8.5% quarter-over-quarter to $1.26B.

Based on Intermede Investment Partners's 13F filing for Q2 2018, filed 8 Aug 2018.